ALDEYRA THERAPEUTICS, INC. Research and Development Expense
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Research and Development Expense of $3.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $3.48M, a 59.03% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $2.41M, a 67.54% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $4.30M, a 70.58% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $5.43M, a 56.35% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. research and development expense for fiscal 2025 was $25.66M, a 46.78% decline from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. research and development expense for fiscal 2024 was $48.22M, a 63.70% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. research and development expense for fiscal 2023 was $29.46M, a 37.73% decline from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. research and development expense for fiscal 2022 was $47.31M, a 5.27% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 116 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.48M 10-Q · filed 2026-08-06 | $5.89M 10-Q · filed 2026-08-06 | $10.20M derived: sum of 3 quarters · filed 2026-08-06 | $15.63M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $2.41M 10-Q · filed 2026-05-07 | $6.71M derived: sum of 2 quarters · filed 2026-05-07 | $12.14M derived: sum of 3 quarters · filed 2026-05-07 | $20.65M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.73M derived: sum of 2 quarters · filed 2026-02-27 | $18.24M derived: sum of 3 quarters · filed 2026-08-06 | $25.66M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $5.43M 10-Q · filed 2025-11-05 | $13.94M derived: sum of 2 quarters · filed 2026-08-06 | $21.36M 10-Q · filed 2025-11-05 | $35.99M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $8.51M 10-Q · filed 2026-08-06 | $15.93M 10-Q · filed 2026-08-06 | $30.56M derived: sum of 3 quarters · filed 2026-08-06 | $43.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $7.42M 10-Q · filed 2026-05-07 | $22.05M derived: sum of 2 quarters · filed 2026-05-07 | $34.49M derived: sum of 3 quarters · filed 2026-05-07 | $49.46M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $14.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $27.07M derived: sum of 2 quarters · filed 2026-02-27 | $42.04M derived: sum of 3 quarters · filed 2026-02-27 | $48.22M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $12.44M 10-Q · filed 2025-11-05 | $27.41M derived: sum of 2 quarters · filed 2025-11-05 | $33.59M 10-Q · filed 2025-11-05 | $37.89M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | $14.97M 10-Q · filed 2025-08-07 | $21.15M 10-Q · filed 2025-08-07 | $25.45M derived: sum of 3 quarters · filed 2025-08-07 | $32.41M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $6.18M 10-Q · filed 2025-05-14 | $10.48M derived: sum of 2 quarters · filed 2025-05-14 | $17.44M derived: sum of 3 quarters · filed 2025-05-14 | $24.41M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.26M derived: sum of 2 quarters · filed 2025-02-28 | $18.22M derived: sum of 3 quarters · filed 2025-02-28 | $29.46M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $6.96M 10-Q · filed 2024-11-07 | $13.92M derived: sum of 2 quarters · filed 2024-11-07 | $25.16M 10-Q · filed 2024-11-07 | $34.12M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $6.96M 10-Q · filed 2024-08-01 | $18.20M 10-Q · filed 2024-08-01 | $27.16M derived: sum of 3 quarters · filed 2024-08-01 | $38.70M derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $11.24M 10-Q · filed 2024-05-02 | $20.20M derived: sum of 2 quarters · filed 2024-05-02 | $31.74M derived: sum of 3 quarters · filed 2024-05-02 | $46.31M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $20.50M derived: sum of 2 quarters · filed 2024-03-07 | $35.07M derived: sum of 3 quarters · filed 2024-03-07 | $47.31M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $11.54M 10-Q · filed 2023-11-03 | $26.11M derived: sum of 2 quarters · filed 2023-11-03 | $38.34M 10-Q · filed 2023-11-03 | $51.19M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $14.57M 10-Q · filed 2023-08-03 | $26.80M 10-Q · filed 2023-08-03 | $39.65M derived: sum of 3 quarters · filed 2023-08-03 | $52.54M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $12.23M 10-Q · filed 2023-05-04 | $25.08M derived: sum of 2 quarters · filed 2023-05-04 | $37.97M derived: sum of 3 quarters · filed 2023-05-04 | $49.44M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $12.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $25.74M derived: sum of 2 quarters · filed 2023-03-09 | $37.21M derived: sum of 3 quarters · filed 2023-03-09 | $44.94M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $12.89M 10-Q · filed 2022-11-10 | $24.37M derived: sum of 2 quarters · filed 2022-11-10 | $32.10M 10-Q · filed 2022-11-10 | $39.12M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $11.47M 10-Q · filed 2022-08-05 | $19.20M 10-Q · filed 2022-08-05 | $26.23M derived: sum of 3 quarters · filed 2022-08-05 | $32.36M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $7.73M 10-Q · filed 2022-05-05 | $14.75M derived: sum of 2 quarters · filed 2022-05-05 | $20.89M derived: sum of 3 quarters · filed 2022-05-05 | $25.77M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $13.16M derived: sum of 2 quarters · filed 2022-03-17 | $18.05M derived: sum of 3 quarters · filed 2022-03-17 | $24.68M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $6.13M 10-Q · filed 2021-10-28 | $11.02M derived: sum of 2 quarters · filed 2021-10-28 | $17.65M 10-Q · filed 2021-10-28 | $27.27M derived: sum of 4 quarters · filed 2021-10-28 | |
| 2020-06-30 | $4.89M 10-Q · filed 2021-08-05 | $11.52M 10-Q · filed 2021-08-05 | $21.13M derived: sum of 3 quarters · filed 2021-08-05 | $37.36M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $6.63M 10-Q · filed 2021-05-06 | $16.25M derived: sum of 2 quarters · filed 2021-05-06 | $32.47M derived: sum of 3 quarters · filed 2021-05-06 | $43.14M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $25.84M derived: sum of 2 quarters · filed 2021-03-11 | $36.50M derived: sum of 3 quarters · filed 2021-03-11 | $44.35M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $16.22M 10-Q · filed 2020-11-05 | $26.89M derived: sum of 2 quarters · filed 2020-11-05 | $34.74M 10-Q · filed 2020-11-05 | $43.29M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $10.66M 10-Q · filed 2020-08-06 | $18.51M 10-Q · filed 2020-08-06 | $27.06M derived: sum of 3 quarters · filed 2020-08-06 | $34.94M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $7.85M 10-Q · filed 2020-05-07 | $16.40M derived: sum of 2 quarters · filed 2020-05-07 | $24.28M derived: sum of 3 quarters · filed 2020-05-07 | $31.07M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $16.43M derived: sum of 2 quarters · filed 2020-03-12 | $23.22M derived: sum of 3 quarters · filed 2020-03-12 | $29.82M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $7.88M 10-Q · filed 2019-11-07 | $14.67M derived: sum of 2 quarters · filed 2019-11-07 | $21.27M 10-Q · filed 2019-11-07 | $26.82M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $6.79M 10-Q · filed 2019-08-09 | $13.39M 10-Q · filed 2019-08-09 | $18.94M derived: sum of 3 quarters · filed 2019-08-09 | $22.48M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $6.60M 10-Q · filed 2019-05-10 | $12.15M derived: sum of 2 quarters · filed 2019-05-10 | $15.68M derived: sum of 3 quarters · filed 2019-05-10 | $19.53M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $9.08M derived: sum of 2 quarters · filed 2019-03-08 | $12.93M derived: sum of 3 quarters · filed 2019-03-08 | $16.30M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $3.54M 10-Q · filed 2018-11-14 | $7.39M derived: sum of 2 quarters · filed 2018-11-14 | $10.76M 10-Q · filed 2018-11-14 | $14.20M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $3.85M 10-Q · filed 2018-08-09 | $7.22M 10-Q · filed 2018-08-09 | $10.67M derived: sum of 3 quarters · filed 2018-08-09 | $14.04M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | $3.37M 10-Q · filed 2018-05-15 | $6.82M derived: sum of 2 quarters · filed 2018-03-29 | $10.20M derived: sum of 3 quarters · filed 2018-03-29 | $13.03M derived: sum of 4 quarters · filed 2018-03-29 | |
| 2016-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $6.83M derived: sum of 2 quarters · filed 2018-03-29 | $9.66M derived: sum of 3 quarters · filed 2018-03-29 | $13.18M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $3.38M 10-Q · filed 2017-11-09 | $6.21M derived: sum of 2 quarters · filed 2017-11-09 | $9.73M 10-Q · filed 2017-11-09 | $12.84M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $2.83M 10-Q · filed 2017-08-07 | $6.35M 10-Q · filed 2017-08-07 | $9.46M derived: sum of 3 quarters · filed 2017-08-07 | $11.53M derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-03-31 | $3.51M 10-Q · filed 2017-05-15 | $6.62M derived: sum of 2 quarters · filed 2017-05-15 | $8.70M derived: sum of 3 quarters · filed 2017-05-15 | $9.95M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $5.19M derived: sum of 2 quarters · filed 2017-03-30 | $6.44M derived: sum of 3 quarters · filed 2017-03-30 | $7.57M 10-K · filed 2017-03-30 | |
| 2015-09-30 | $2.08M 10-Q · filed 2016-11-14 | $3.33M derived: sum of 2 quarters · filed 2016-11-14 | $4.46M 10-Q · filed 2016-11-14 | $5.87M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $1.25M 10-Q · filed 2016-08-10 | $2.39M 10-Q · filed 2016-08-10 | $3.79M derived: sum of 3 quarters · filed 2016-08-10 | $4.98M derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | $1.14M 10-Q · filed 2016-05-09 | $2.54M derived: sum of 2 quarters · filed 2016-05-09 | $3.74M derived: sum of 3 quarters · filed 2016-05-09 | $4.40M derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $2.60M derived: sum of 2 quarters · filed 2016-03-30 | $3.26M derived: sum of 3 quarters · filed 2016-03-30 | $3.71M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $1.20M 10-Q · filed 2015-11-13 | $1.86M derived: sum of 2 quarters · filed 2015-11-13 | $2.30M 10-Q · filed 2015-11-13 | $2.70M derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $663.91K 10-Q · filed 2015-08-14 | $1.11M 10-Q · filed 2015-08-14 | $1.51M derived: sum of 3 quarters · filed 2015-08-14 | $2.17M derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $444.28K 10-Q · filed 2015-05-14 | $844.64K derived: sum of 2 quarters · filed 2015-05-14 | $1.51M derived: sum of 3 quarters · filed 2015-05-14 | $1.84M derived: sum of 4 quarters · filed 2015-05-14 | $13.29M 10-Q · filed 2014-06-11 |
| 2013-12-31 | $400.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $1.07M derived: sum of 2 quarters · filed 2015-03-23 | $1.39M derived: sum of 3 quarters · filed 2015-03-23 | $1.54M 10-K · filed 2015-03-23 | |
| 2013-09-30 | $666.04K 10-Q · filed 2014-11-12 | $991.09K derived: sum of 2 quarters · filed 2014-11-12 | $1.14M 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $325.05K 10-Q · filed 2014-08-07 | $475.28K 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $150.23K 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |